{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:39:10Z","timestamp":1794631150309,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Herzzentrum M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited data is available for long-term outcomes after percutaneous coronary intervention (PCI) of coronary drug-eluting stent (DES) in-stent restenosis (ISR) in diabetics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Thus, the aim of this observational, retrospective study was to close this lack of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January 2007 and February 2021, a total of 3511 patients with 5497 ISR lesions were treated at two large-volume centers in Munich, Germany, of which 1242 (35.4%) were diabetics. Endpoints of interest were the rates of cardiac death, repeat revascularization, and myocardial infarction (MI). Survival was analyzed using the Kaplan\u2013Meier method. Differences between the groups were tested with the log-rank test. Conventional multivariable analysis with adjustment for relevant variables was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 10 years, the rates of cardiac death were 42.8% for diabetics and 32.8% for nondiabetics (HR\n                      <jats:sub>adj<\/jats:sub>\n                      1.55 [95% CI, 1.31\u20131.81],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). MI occurred in 15.9% of diabetics and in 9.7% of non-diabetics (HR\n                      <jats:sub>adj<\/jats:sub>\n                      1.70 [95% CI, 1.36\u20132.11],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The rates of repeat revascularization of target lesion (HR\n                      <jats:sub>adj<\/jats:sub>\n                      1.17 [95% CI, 1.02\u20131.34],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028), target vessel, and nontarget vessel were significantly higher in diabetics as compared to nondiabetics. No statistically relevant difference was found regarding the rate of stent thrombosis. Compared to non-insulin-dependent diabetics, insulin-dependent diabetics show higher rates of cardiac death and MI, but comparable revascularization rates in both diabetic groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the long term, the rates of cardiac death, MI, and repeat revascularization after PCI of DES-ISR are significantly higher in diabetics, particularly in insulin-dependent diabetics, than in nondiabetics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-025-02782-6","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:00:14Z","timestamp":1762182014000},"page":"132-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis"],"prefix":"10.1007","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0154-6514","authenticated-orcid":false,"given":"Constantin","family":"Kuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bradaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Presch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kufner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2782_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.carrev.2023.02.006","volume":"52","author":"B Duband","year":"2023","unstructured":"Duband B, Souteyrand G, Clerc JM, Chassaing S, Fichaux O, Marcollet P, Deballon R, Roussel L, Pereira B, Collet JP et al (2023) Prevalence, management and outcomes of percutaneous coronary intervention for coronary in-stent restenosis: insights from the France PCI registry. Cardiovasc Revasc Med 52:39\u201346. https:\/\/doi.org\/10.1016\/j.carrev.2023.02.006","journal-title":"Cardiovasc Revasc Med"},{"key":"2782_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","volume":"75","author":"MV Madhavan","year":"2020","unstructured":"Madhavan MV, Kirtane AJ, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C et al (2020) Stent-related adverse events >1 year after percutaneous coronary intervention. J Am Coll Cardiol 75:590\u2013604. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.058","journal-title":"J Am Coll Cardiol"},{"key":"2782_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/eurheartj\/ehu383","volume":"36","author":"S Cassese","year":"2015","unstructured":"Cassese S, Byrne RA, Schulz S, Hoppman P, Kreutzer J, Feuchtenberger A, Ibrahim T, Ott I, Fusaro M, Schunkert H et al (2015) Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting. Eur Heart J 36:94\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehu383","journal-title":"Eur Heart J"},{"key":"2782_CR4","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jacc.2020.08.002","volume":"76","author":"ID Moussa","year":"2020","unstructured":"Moussa ID, Mohananey D, Saucedo J, Stone GW, Yeh RW, Kennedy KF, Waksman R, Teirstein P, Moses JW, Simonton C (2020) Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol 76:1521\u20131531. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2782_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2018","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ et al (2018) 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J 40(2):87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394","journal-title":"Eur Heart J"},{"key":"2782_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029300","volume":"12","author":"A Elbadawi","year":"2023","unstructured":"Elbadawi A, Dang AT, Mahana I, Elzeneini M, Alonso F, Banerjee S, Kumbhani DJ, Elgendy IY, Mintz GS (2023) Outcomes of percutaneous coronary intervention for in-stent restenosis versus de novo lesions: a meta-analysis. J Am Heart Assoc 12:e029300. https:\/\/doi.org\/10.1161\/JAHA.122.029300","journal-title":"J Am Heart Assoc"},{"key":"2782_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC et al (2022) IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119","journal-title":"Diabetes Res Clin Pract"},{"key":"2782_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson D, Rayfield EJ (2002) How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1:1. https:\/\/doi.org\/10.1186\/1475-2840-1-1","journal-title":"Cardiovasc Diabetol"},{"key":"2782_CR9","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","volume":"63","author":"E Kedhi","year":"2014","unstructured":"Kedhi E, Genereux P, Palmerini T, McAndrew TC, Parise H, Mehran R, Dangas GD, Stone GW (2014) Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. J Am Coll Cardiol 63:2111\u20132118. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.064","journal-title":"J Am Coll Cardiol"},{"key":"2782_CR10","doi-asserted-by":"publisher","unstructured":"Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 55:432\u2013440. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.014","DOI":"10.1016\/j.jacc.2009.10.014"},{"key":"2782_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ahj.2012.02.014","volume":"163","author":"M Billinger","year":"2012","unstructured":"Billinger M, Raber L, Hitz S, Stefanini GG, Pilgrim T, Stettler C, Zanchin T, Pulver C, Pfaffli N, Eberli F et al (2012) Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents. Am Heart J 163:876. https:\/\/doi.org\/10.1016\/j.ahj.2012.02.014","journal-title":"Am Heart J"},{"key":"2782_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","volume":"154","author":"R Iijima","year":"2007","unstructured":"Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schomig A, Kastrati A (2007) Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J 154:688\u2013693. https:\/\/doi.org\/10.1016\/j.ahj.2007.06.005","journal-title":"Am Heart J"},{"key":"2782_CR13","doi-asserted-by":"publisher","unstructured":"Alfonso F, Byrne RA, Rivero F, Kastrati A (2014) Current treatment of in-stent restenosis. J Am Coll Cardiol 63:2659\u20132673. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.545","DOI":"10.1016\/j.jacc.2014.02.545"},{"key":"2782_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0445-6","volume":"17","author":"L Zhao","year":"2017","unstructured":"Zhao L, Zhu W, Zhang X, He D, Guo C (2017) Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis. BMC Cardiovasc Disord 17:16. https:\/\/doi.org\/10.1186\/s12872-016-0445-6","journal-title":"BMC Cardiovasc Disord"},{"key":"2782_CR15","doi-asserted-by":"publisher","unstructured":"Mohebi R, Chen C, Ibrahim NE, McCarthy CP, Gaggin HK, Singer DE, Hyle EP, Wasfy JH, Januzzi JL Jr. (2022) Cardiovascular disease projections in the United States based on the 2020 census estimates. J Am Coll Cardiol 80:565\u2013578. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.033","DOI":"10.1016\/j.jacc.2022.05.033"},{"key":"2782_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131856","volume":"401","author":"R Tanner","year":"2024","unstructured":"Tanner R, Farhan S, Giustino G, Sartori S, Feng Y, Hooda A, Vinayak M, Dangas G, Mehran R, Kini AS et al (2024) Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: results from a large registry. Int J Cardiol 401:131856. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131856","journal-title":"Int J Cardiol"},{"key":"2782_CR17","first-page":"28","volume":"23","author":"G Paramasivam","year":"2020","unstructured":"Paramasivam G, Devasia T, Jayaram A, U KA, Rao MS, Vijayvergiya R, Nayak K (2020) In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: clinical presentation, angiographic features, and outcomes. Anatol J Cardiol 23:28\u201334","journal-title":"Anatol J Cardiol"},{"key":"2782_CR18","doi-asserted-by":"publisher","unstructured":"Expert Committee on the D, Classification of Diabetes M (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 26 Suppl 1:S5\u201320. https:\/\/doi.org\/10.2337\/diacare.26.2007.s5","DOI":"10.2337\/diacare.26.2007.s5"},{"key":"2782_CR19","doi-asserted-by":"publisher","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESCAAHAWHFTFftUDoMI, Katus HA, Lindahl B, Morrow DA, et al. (2012) Third universal definition of myocardial infarction. Circulation. 126:2020\u20132035. https:\/\/doi.org\/10.1161\/CIR.0b013e31826e1058","DOI":"10.1161\/CIR.0b013e31826e1058"},{"key":"2782_CR20","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344\u20132351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.685313","journal-title":"Circulation"},{"key":"2782_CR21","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B et al (2018) Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document. Circulation 137:2635\u20132650. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029289","journal-title":"Circulation"},{"key":"2782_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ccl.2014.04.001","volume":"32","author":"D Aronson","year":"2014","unstructured":"Aronson D, Edelman ER (2014) Coronary artery disease and diabetes mellitus. Cardiol Clin 32:439\u2013455. https:\/\/doi.org\/10.1016\/j.ccl.2014.04.001","journal-title":"Cardiol Clin"},{"key":"2782_CR23","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein M, Ben-Yehuda O, Smits PC, Love MP, Banai S, Perlman GY, Golomb M, Ozan MO, Liu M, Leon MB et al (2018) Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial. JACC Cardiovasc Interv 11:2467\u20132476. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.033","journal-title":"JACC Cardiovasc Interv"},{"key":"2782_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.003255","volume":"9","author":"KC Koskinas","year":"2016","unstructured":"Koskinas KC, Siontis GC, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, Silber S, Serruys PW, Pilgrim T, Raber L et al (2016) Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: patient-level pooled analysis of 6081 patients. Circ Cardiovasc Interv 9:e003255. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.115.003255","journal-title":"Circ Cardiovasc Interv"},{"key":"2782_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.4244\/EIJV5I8A152","volume":"5","author":"A Norhammar","year":"2010","unstructured":"Norhammar A, Lagerqvist B, Saleh N (2010) Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention 5:891\u2013897","journal-title":"EuroIntervention"},{"key":"2782_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072710","volume":"8","author":"SY Qin","year":"2013","unstructured":"Qin SY, Zhou Y, Jiang HX, Hu BL, Tao L, Xie MZ (2013) The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis. PLoS ONE 8:e72710. https:\/\/doi.org\/10.1371\/journal.pone.0072710","journal-title":"PLoS ONE"},{"key":"2782_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000766","volume":"141","author":"SV Arnold","year":"2020","unstructured":"Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD et al (2020) Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association. Circulation 141:e779\u2013e806. https:\/\/doi.org\/10.1161\/CIR.0000000000000766","journal-title":"Circulation"},{"key":"2782_CR28","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0939","volume":"44","author":"P Mone","year":"2021","unstructured":"Mone P, Gambardella J, Minicucci F, Lombardi A, Mauro C, Santulli G (2021) Hyperglycemia drives stent restenosis in STEMI patients. Diabetes Care 44:e192\u2013e193. https:\/\/doi.org\/10.2337\/dc21-0939","journal-title":"Diabetes Care"},{"key":"2782_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCA.0000000000000170","volume":"26","author":"LP Zhao","year":"2015","unstructured":"Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ (2015) Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Coron Artery Dis 26:5\u201310. https:\/\/doi.org\/10.1097\/MCA.0000000000000170","journal-title":"Coron Artery Dis"},{"key":"2782_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","volume":"92","author":"SJ Hong","year":"2006","unstructured":"Hong SJ, Kim MH, Ahn TH, Ahn YK, Bae JH, Shim WJ, Ro YM, Lim DS (2006) Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart 92:1119\u20131124. https:\/\/doi.org\/10.1136\/hrt.2005.075960","journal-title":"Heart"},{"key":"2782_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1253\/jcj.65.947","volume":"65","author":"M Imazu","year":"2001","unstructured":"Imazu M, Sumii K, Yamamoto H, Toyofuku M, Okimoto T, Gomyo Y, Ueda H, Hayashi Y, Kohno N (2001) Hyperinsulinemia as a risk factor for restenosis after coronary balloon angioplasty. Jpn Circ J 65:947\u2013952. https:\/\/doi.org\/10.1253\/jcj.65.947","journal-title":"Jpn Circ J"},{"key":"2782_CR32","first-page":"3003","volume":"94","author":"D Aronson","year":"1996","unstructured":"Aronson D (1996) Restenosis in diabetic patients: is hyperinsulinemia the culprit? Circulation 94:3003\u20133005","journal-title":"Circulation"},{"key":"2782_CR33","doi-asserted-by":"publisher","first-page":"990","DOI":"10.2337\/diacare.27.4.990","volume":"27","author":"J Gilbert","year":"2004","unstructured":"Gilbert J, Raboud J, Zinman B (2004) Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care 27:990\u2013994. https:\/\/doi.org\/10.2337\/diacare.27.4.990","journal-title":"Diabetes Care"},{"key":"2782_CR34","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","volume":"121","author":"SH Pi","year":"2018","unstructured":"Pi SH, Rhee TM, Lee JM, Hwang D, Park J, Park TK, Yang JH, Song YB, Choi JH, Hahn JY et al (2018) Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era. Am J Cardiol 121:1505\u20131511. https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.034","journal-title":"Am J Cardiol"},{"key":"2782_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjcard.2021.02.025","volume":"148","author":"S Biswas","year":"2021","unstructured":"Biswas S, Dinh D, Andrianopoulos N, Lefkovits J, Ajani A, Duffy SJ, Chan W, Walton A, Brennan A, Clark DJ et al (2021) Comparison of long-term outcomes after percutaneous coronary intervention in patients with insulin-treated versus non-insulin treated diabetes mellitus. Am J Cardiol 148:36\u201343. https:\/\/doi.org\/10.1016\/j.amjcard.2021.02.025","journal-title":"Am J Cardiol"},{"key":"2782_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00041433-199912000-00004","volume":"10","author":"R Virmani","year":"1999","unstructured":"Virmani R, Farb A (1999) Pathology of in-stent restenosis. Curr Opin Lipidol 10:499\u2013506. https:\/\/doi.org\/10.1097\/00041433-199912000-00004","journal-title":"Curr Opin Lipidol"},{"key":"2782_CR37","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, Kutys R, Xhepa E, Kastrati A, Virmani R et al (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 36:2147\u20132159. https:\/\/doi.org\/10.1093\/eurheartj\/ehv205","journal-title":"Eur Heart J"},{"key":"2782_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijcard.2006.08.082","volume":"120","author":"G Marazzi","year":"2007","unstructured":"Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M et al (2007) Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Int J Cardiol 120:79\u201384. https:\/\/doi.org\/10.1016\/j.ijcard.2006.08.082","journal-title":"Int J Cardiol"},{"key":"2782_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead083","volume":"3","author":"F Pelliccia","year":"2023","unstructured":"Pelliccia F, Zimarino M, Niccoli G, Morrone D, De Luca G, Miraldi F, De Caterina R (2023) In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways. Eur Heart J Open 3:oead083. https:\/\/doi.org\/10.1093\/ehjopen\/oead083","journal-title":"Eur Heart J Open"},{"key":"2782_CR40","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/eurheartj\/ehm175","volume":"28","author":"LO Jensen","year":"2007","unstructured":"Jensen LO, Thayssen P, Mintz GS, Maeng M, Junker A, Galloe A, Christiansen EH, Hoffmann SK, Pedersen KE, Hansen HS et al (2007) Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J 28:1759\u20131764. https:\/\/doi.org\/10.1093\/eurheartj\/ehm175","journal-title":"Eur Heart J"},{"key":"2782_CR41","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/01.cir.99.17.2239","volume":"99","author":"A Abaci","year":"1999","unstructured":"Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239\u20132242. https:\/\/doi.org\/10.1161\/01.cir.99.17.2239","journal-title":"Circulation"},{"key":"2782_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/14779072.2014.853615","volume":"12","author":"C Bernelli","year":"2014","unstructured":"Bernelli C, Chan J, Chieffo A (2014) Drug-eluting stent outcomes in diabetes. Expert Rev Cardiovasc Ther 12:95\u2013109. https:\/\/doi.org\/10.1586\/14779072.2014.853615","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2782_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","volume":"80","author":"G Giustino","year":"2022","unstructured":"Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, Kini A, Sharma SK (2022) Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol 80:348\u2013372. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.017","journal-title":"J Am Coll Cardiol"},{"key":"2782_CR44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1714\/4375.43725","volume":"25","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA et al (2024) 2024 ESC guidelines for the management of chronic coronary syndromes. G Ital Cardiol (Rome) 25:e1\u2013e132. https:\/\/doi.org\/10.1714\/4375.43725","journal-title":"G Ital Cardiol (Rome)"},{"key":"2782_CR45","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","volume":"75","author":"D Giacoppo","year":"2020","unstructured":"Giacoppo D, Alfonso F, Xu B, Claessen B, Adriaenssens T, Jensen C, Perez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L et al (2020) Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol 75:2664\u20132678. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.006","journal-title":"J Am Coll Cardiol"},{"key":"2782_CR46","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/eurheartj\/ehad026","volume":"44","author":"D Giacoppo","year":"2023","unstructured":"Giacoppo D, Alvarez-Covarrubias HA, Koch T, Cassese S, Xhepa E, Kessler T, Wiebe J, Joner M, Hochholzer W, Laugwitz KL et al (2023) Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial. Eur Heart J 44:1343\u20131357. https:\/\/doi.org\/10.1093\/eurheartj\/ehad026","journal-title":"Eur Heart J"},{"key":"2782_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjcard.2023.08.113","volume":"206","author":"M Verdoia","year":"2023","unstructured":"Verdoia M, Zilio F, Gioscia R, Viola O, Brancati MF, Fanti D, Solda PL, Bonmassari R, Rognoni A, De Luca G (2023) Prognostic impact of drug-coated balloons in patients with diabetes mellitus: a propensity-matched study. Am J Cardiol 206:73\u201378. https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.113","journal-title":"Am J Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02782-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:33:17Z","timestamp":1767864797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02782-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2782"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02782-6","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics board of the Technical University Munich, Germany, and adheres to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"CK reports speaker fees from AstraZeneca and Translumina. FV reports speaker fees from Abbott, AstraZeneca, ShockWave, and Translumina and educational grants from Abbott, Bentley Innomed, and SIS-Medical. TK reports speaker fees from B. Braun Melsungen. SK reports speaker and consulting fees from AstraZeneca, Bristol-Myers Squibb, and Bentley, and speaker fees from Abbott, Boehringer-Ingelheim, and Translumina and a research grant from Bentley, not related to the current work. HS reports lecture fees from AstraZeneca, Bayer Vital, MSD Sharp & Dohme, Novartis, Servier, Sanofi-Aventis, Synlab, and Bristol-Myers Squibb, consulting fees from MSD Sharp & Dohme, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, and Servier, and external funds from AstraZeneca, St. Jude, and Boston Scientific. JW reports lecture fees from Abbott Vascular, AstraZeneca, Philips, and Translumina and received Institutional Research Grant support from Abbott Vascular. The other authors declare no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}